Heterogeneous EGFR-mutated lung adenocarcinomas undergo clonal selection upon treatment of EGFR TKIs. There are sequences of changes in clonal predominance upon treatment exposure/adaptation to 1st & 2nd and subsequently 3rd generation EGFR TKIs.
We have placed cookies on your device to make our website better. If you continue using our website, we assume you agree to it. You can learn more details here .
